Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 0 | 9,747 |
| Other current assets | 0 | 0 | 0 | 0 | 740 |
| TOTAL | $0 | $N/A | $0 | $0 | $10,487 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 1,042 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 70 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $1,112 |
| Total Assets | $0 | $N/A | $0 | $0 | $11,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 460 |
| Accrued Expenses | 0 | N/A | 0 | 0 | 140 |
| Other current liabilities | 0 | N/A | 0 | 0 | 30 |
| TOTAL | $0 | $N/A | $0 | $0 | $651 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 20 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $20 |
| Total Liabilities | $0 | $N/A | $0 | $0 | $676 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 0 | 0 | 1 |
| Retained earnings | 0 | N/A | 0 | 0 | -17,511 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 28,028 |
| TOTAL | $0 | $N/A | $0 | $0 | $10,748 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $11,424 |